These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 35134572)

  • 1. Impaired nuclear transport induced by juvenile ALS causing P525L mutation in NLS domain of FUS: A molecular mechanistic study.
    Basu S; Rajendra KC; Alagar S; Bahadur RP
    Biochim Biophys Acta Proteins Proteom; 2022 Apr; 1870(4):140766. PubMed ID: 35134572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of karyopherin-β2 binding and nuclear import of ALS variants FUS(P525L) and FUS(R495X).
    Gonzalez A; Mannen T; Çağatay T; Fujiwara A; Matsumura H; Niesman AB; Brautigam CA; Chook YM; Yoshizawa T
    Sci Rep; 2021 Feb; 11(1):3754. PubMed ID: 33580145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural and energetic basis of ALS-causing mutations in the atypical proline-tyrosine nuclear localization signal of the Fused in Sarcoma protein (FUS).
    Zhang ZC; Chook YM
    Proc Natl Acad Sci U S A; 2012 Jul; 109(30):12017-21. PubMed ID: 22778397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. R521C and R521H mutations in FUS result in weak binding with Karyopherinβ2 leading to Amyotrophic lateral sclerosis: a molecular docking and dynamics study.
    Swetha RG; Ramaiah S; Anbarasu A
    J Biomol Struct Dyn; 2017 Aug; 35(10):2169-2185. PubMed ID: 27381509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arginine methylation next to the PY-NLS modulates Transportin binding and nuclear import of FUS.
    Dormann D; Madl T; Valori CF; Bentmann E; Tahirovic S; Abou-Ajram C; Kremmer E; Ansorge O; Mackenzie IR; Neumann M; Haass C
    EMBO J; 2012 Nov; 31(22):4258-75. PubMed ID: 22968170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ALS-associated fused in sarcoma (FUS) mutations disrupt Transportin-mediated nuclear import.
    Dormann D; Rodde R; Edbauer D; Bentmann E; Fischer I; Hruscha A; Than ME; Mackenzie IR; Capell A; Schmid B; Neumann M; Haass C
    EMBO J; 2010 Aug; 29(16):2841-57. PubMed ID: 20606625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transportin 1 colocalization with Fused in Sarcoma (FUS) inclusions is not characteristic for amyotrophic lateral sclerosis-FUS confirming disrupted nuclear import of mutant FUS and distinguishing it from frontotemporal lobar degeneration with FUS inclusions.
    Troakes C; Hortobágyi T; Vance C; Al-Sarraj S; Rogelj B; Shaw CE
    Neuropathol Appl Neurobiol; 2013 Aug; 39(5):553-61. PubMed ID: 22934812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear Import Receptor Inhibits Phase Separation of FUS through Binding to Multiple Sites.
    Yoshizawa T; Ali R; Jiou J; Fung HYJ; Burke KA; Kim SJ; Lin Y; Peeples WB; Saltzberg D; Soniat M; Baumhardt JM; Oldenbourg R; Sali A; Fawzi NL; Rosen MK; Chook YM
    Cell; 2018 Apr; 173(3):693-705.e22. PubMed ID: 29677513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase Separation of FUS Is Suppressed by Its Nuclear Import Receptor and Arginine Methylation.
    Hofweber M; Hutten S; Bourgeois B; Spreitzer E; Niedner-Boblenz A; Schifferer M; Ruepp MD; Simons M; Niessing D; Madl T; Dormann D
    Cell; 2018 Apr; 173(3):706-719.e13. PubMed ID: 29677514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear import factor transportin and arginine methyltransferase 1 modify FUS neurotoxicity in Drosophila.
    Jäckel S; Summerer AK; Thömmes CM; Pan X; Voigt A; Schulz JB; Rasse TM; Dormann D; Haass C; Kahle PJ
    Neurobiol Dis; 2015 Feb; 74():76-88. PubMed ID: 25447237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FUS-NLS/Transportin 1 complex structure provides insights into the nuclear targeting mechanism of FUS and the implications in ALS.
    Niu C; Zhang J; Gao F; Yang L; Jia M; Zhu H; Gong W
    PLoS One; 2012; 7(10):e47056. PubMed ID: 23056579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired DNA damage response signaling by FUS-NLS mutations leads to neurodegeneration and FUS aggregate formation.
    Naumann M; Pal A; Goswami A; Lojewski X; Japtok J; Vehlow A; Naujock M; Günther R; Jin M; Stanslowsky N; Reinhardt P; Sterneckert J; Frickenhaus M; Pan-Montojo F; Storkebaum E; Poser I; Freischmidt A; Weishaupt JH; Holzmann K; Troost D; Ludolph AC; Boeckers TM; Liebau S; Petri S; Cordes N; Hyman AA; Wegner F; Grill SW; Weis J; Storch A; Hermann A
    Nat Commun; 2018 Jan; 9(1):335. PubMed ID: 29362359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abl kinase-mediated FUS Tyr526 phosphorylation alters nucleocytoplasmic FUS localization in FTLD-FUS.
    Motaln H; Čerček U; Yamoah A; Tripathi P; Aronica E; Goswami A; Rogelj B
    Brain; 2023 Oct; 146(10):4088-4104. PubMed ID: 37071594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transportin 1 accumulates specifically with FET proteins but no other transportin cargos in FTLD-FUS and is absent in FUS inclusions in ALS with FUS mutations.
    Neumann M; Valori CF; Ansorge O; Kretzschmar HA; Munoz DG; Kusaka H; Yokota O; Ishihara K; Ang LC; Bilbao JM; Mackenzie IR
    Acta Neuropathol; 2012 Nov; 124(5):705-16. PubMed ID: 22842875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FUS P525L mutation causing amyotrophic lateral sclerosis and movement disorders.
    Zhou B; Wang H; Cai Y; Wen H; Wang L; Zhu M; Chen Y; Yu Y; Lu X; Zhou M; Fang P; Li X; Hong D
    Brain Behav; 2020 Jun; 10(6):e01625. PubMed ID: 32307925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FUS mutation is probably the most common pathogenic gene for JALS, especially sporadic JALS.
    Chen L
    Rev Neurol (Paris); 2021 Apr; 177(4):333-340. PubMed ID: 33036763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. U1 snRNP is mislocalized in ALS patient fibroblasts bearing NLS mutations in FUS and is required for motor neuron outgrowth in zebrafish.
    Yu Y; Chi B; Xia W; Gangopadhyay J; Yamazaki T; Winkelbauer-Hurt ME; Yin S; Eliasse Y; Adams E; Shaw CE; Reed R
    Nucleic Acids Res; 2015 Mar; 43(6):3208-18. PubMed ID: 25735748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylation of C-terminal tyrosine residue 526 in FUS impairs its nuclear import.
    Darovic S; Prpar Mihevc S; Župunski V; Gunčar G; Štalekar M; Lee YB; Shaw CE; Rogelj B
    J Cell Sci; 2015 Nov; 128(22):4151-9. PubMed ID: 26403203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ALS-Related Mutant FUS Protein Is Mislocalized to Cytoplasm and Is Recruited into Stress Granules of Fibroblasts from Asymptomatic FUS P525L Mutation Carriers.
    Lo Bello M; Di Fini F; Notaro A; Spataro R; Conforti FL; La Bella V
    Neurodegener Dis; 2017; 17(6):292-303. PubMed ID: 29035885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ALS-Associated FUS (P525L) Variant Does Not Directly Interfere with Microtubule-Dependent Kinesin-1 Motility.
    Seifert A; Drechsler H; Japtok J; Korten T; Diez S; Hermann A
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33670886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.